Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Resomelagon acetate
Cat. No.:
OB0425LY-155
Appearance:
Solid
Purity:
99.75%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Resomelagon acetate is the acetate form of Resomelagon that has better drug stability or bioavailability.
Synonyms:
AP1189; AP1189 acetate; Resomelagon (acetate); 959850-74-9; AP-1189; 1809420-72-1; (E/Z)-Resomelagon (acetatE); Hydrazinecarboximidamide, 2-[(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-2-propen-1-ylidene]-, acetate (1:1), (2E)-
CAS No.:
1809420-72-1
Compound CID:
163358504
Formula:
C16H18N6O4
Formula Weight:
358.35
Specification
Target:
Melanocortin receptor
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
Resomelagon acetate can be used in obesity and chronic inflammation studies.
